#AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart. Full results and Research Summary of the EARLY-AF trial: https://t.co/ZjLkt9L2xr #AFibAwarenessMonth
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2022 – Jan 2025Where it's discussed
-
X / Twitter187 posts
-
News52 articles
-
Blogs6 articles
-
Facebook5 posts
-
YouTube2 videos
AI synopsis
What people are saying
Several discussions highlight the key findings of the research, such as the clear advantages of cryoablation over antiarrhythmic drugs in reducing AF progression. Phrases like 'transformative potential' and 'time to rethink our approach' reflect a sense of urgency and importance, showcasing how the tone and language contribute to the overall positive sentiment about the publication's impact on clinical practices.
The majority of the discussions reflect a consensus on the benefits of cryoablation over drug therapy for managing AF.
There is strong curiosity demonstrated in various posts, indicating relevance and a desire for more information about the publication.
Many discussions provide detailed analysis and implications of the findings, suggesting a deep understanding and interest in the subject matter.
Users perceive the research as having significant implications for treatment approaches, emphasizing its potential to change standard practices.
Abstract in brief
- Atrial fibrillation (AF) is a chronic condition linked to higher risks of complications like stroke and heart failure, and catheter ablation may help prevent its progression.
- The study reported on a trial comparing cryoballoon ablation and antiarrhythmic drug therapy over three years for patients with untreated paroxysmal AF, using implantable loop recorders for monitoring.
- Results showed that patients in the ablation group had significantly fewer episodes of persistent AF and recurrent atrial tachyarrhythmias compared to those receiving drug therapy, indicating a beneficial effect of cryoablation in managing AF progression.
Top posts
Most liked on X and BlueskyEARLY-AF trial; artículo original por @NEJM
We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ablation decreases progression vs AAD therapy. Join us at ESC for late-breaking science comparing cryoballoon ablation and RF ablation https://t.co/dO410eFTg3 https://t.co/mtOEGkDebY
No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramos los resultados. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/NWzSRcr8KD
.@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ablation decreases progression of atrial fibrillation✨ https://t.co/O65uRVhRIO PROGRESSIVE-AF from @DrJasonAndrade: https://t.co/aT7Qoid6XR #WAFib2023 https://t.co/apxeaaoaVQ
Important data re negative impact of AF progression. This echoes the Fushimi AF registry, showing that progression from paroxysmal to persistent AF is associated with worse outcomes We need to focus on the value of interventions to prevent progression https://t.co/dO410eGr5B https://t.co/S3UDBQc8nB
All mentions
Early vs Delayed Atrial Fibrillation Catheter Ablation Insights
John Mandrola MD discusses early vs delayed AF ablation, highlighting a study that shows cryoablation significantly reduces persistent AF episodes compared to drug therapy. This video is aimed at healthcare…
Atrial Fibrillation Management: Cryoablation vs Drug Therapy
This podcast discusses recent trials including IRONMAN and ECMOCS, focusing on treatment options for atrial fibrillation. It reviews the effectiveness of cryoballoon ablation compared to antiarrhythmic drugs…
RT @DrJasonAndrade: But observational evidence doesn't tell us about treatment effects, so the issue remained unresolved In the past few y…
But observational evidence doesn't tell us about treatment effects, so the issue remained unresolved In the past few years we have seen 5 RCTs compare pharmacotherapy to catheter ablation as a first, second, or third line therapy https://t.co/dO410eGr5B https://t.co/PrT0aWWtt7 https://t.co/HTRlpynvm2
RT @DrJasonAndrade: Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to @AHAScienc…
RT @DrJasonAndrade: Interesting results but I would interpret with caution. 1. The HRQOL metric was insensitive to change within the dise…
RT @DrJasonAndrade: Interesting results but I would interpret with caution. 1. The HRQOL metric was insensitive to change within the dise…
RT @DrJasonAndrade: Interesting results but I would interpret with caution. 1. The HRQOL metric was insensitive to change within the dise…
Interesting results but I would interpret with caution. 1. The HRQOL metric was insensitive to change within the disease state and thus the lack of difference is to be expected. 2. In contrast - 3 year differences in wok were preserved a larger RCT https://t.co/dO410eGr5B https://t.co/kT2uttwRvz
RT @DrJasonAndrade: Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to @AHAScienc…
RT @DrJasonAndrade: Important data re negative impact of AF progression. This echoes the Fushimi AF registry, showing that progression fr…
RT @DrJasonAndrade: Important data re negative impact of AF progression. This echoes the Fushimi AF registry, showing that progression fr…
RT @DrJasonAndrade: Important data re negative impact of AF progression. This echoes the Fushimi AF registry, showing that progression fr…
RT @DrJasonAndrade: Important data re negative impact of AF progression. This echoes the Fushimi AF registry, showing that progression fr…
Important data re negative impact of AF progression. This echoes the Fushimi AF registry, showing that progression from paroxysmal to persistent AF is associated with worse outcomes We need to focus on the value of interventions to prevent progression https://t.co/dO410eGr5B https://t.co/S3UDBQc8nB
RT @KagawaECG: アブレーションは持続性心房細動への移行を減らす _φ(・_・ . イラストが綺麗☺️ . #JHRS2024 . Progression of Atrial Fibrillation after Cryoablation or Drug Ther…
RT @KagawaECG: アブレーションは持続性心房細動への移行を減らす _φ(・_・ . イラストが綺麗☺️ . #JHRS2024 . Progression of Atrial Fibrillation after Cryoablation or Drug Ther…
RT @KagawaECG: アブレーションは持続性心房細動への移行を減らす _φ(・_・ . イラストが綺麗☺️ . #JHRS2024 . Progression of Atrial Fibrillation after Cryoablation or Drug Ther…
アブレーションは持続性心房細動への移行を減らす _φ(・_・ . イラストが綺麗☺️ . #JHRS2024 . Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | New England Journal of Medicine https://t.co/eoXg5pJKNF
En nuestro #BlogDeFellows de hoy, hablaremos sobre la "Progresión de la fibrilación auricular después de crioablación o tratamiento farmacológico". Encuéntralo completo aquí: https://t.co/wLvLd2B9nw #Educación #Ciencia #Cardiología #Lectura
RT @DrJasonAndrade: While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that kn…
RT @DrJasonAndrade: While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that kn…
RT @DrJasonAndrade: While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that kn…
RT @DrJasonAndrade: Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to @AHAScienc…
RT @DrJasonAndrade: While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that kn…
RT @DrJasonAndrade: While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that kn…
RT @DrJasonAndrade: While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that kn…
While the publication of EARLY-AF / PROGRESSIVE-AF has been informative, there remains a key gap is translating that knowledge to primary and specialist care. The care of electrophysiologists is too late in the treatment paradigm https://t.co/5lxFeqWv8a https://t.co/dO410eFTg3
Progression of #Atrial Fibrillation after Cryoablation or Drug Therapy https://t.co/pBqFCW3sGx
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/gdGwlnXBKE
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
RT @NEJM: #AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart.…
#AFib may progress over time from a paroxysmal to a persistent form because of electrical and structural remodeling of the heart. Full results and Research Summary of the EARLY-AF trial: https://t.co/ZjLkt9L2xr #AFibAwarenessMonth
RT @DrJCheungEP: @PacingSpike @PamelaMasonEP @ACCinTouch @EPeeps_Bot @ArunRSridhar @DrRachitaEP @NazemAkoum @KTamirisaMD @rajeshkabramd @Mo…
RT @DrJCheungEP: @PacingSpike @PamelaMasonEP @ACCinTouch @EPeeps_Bot @ArunRSridhar @DrRachitaEP @NazemAkoum @KTamirisaMD @rajeshkabramd @Mo…
RT @DrJCheungEP: @PacingSpike @PamelaMasonEP @ACCinTouch @EPeeps_Bot @ArunRSridhar @DrRachitaEP @NazemAkoum @KTamirisaMD @rajeshkabramd @Mo…
RT @DrJCheungEP: @PacingSpike @PamelaMasonEP @ACCinTouch @EPeeps_Bot @ArunRSridhar @DrRachitaEP @NazemAkoum @KTamirisaMD @rajeshkabramd @Mo…
RT @DrJCheungEP: @PacingSpike @PamelaMasonEP @ACCinTouch @EPeeps_Bot @ArunRSridhar @DrRachitaEP @NazemAkoum @KTamirisaMD @rajeshkabramd @Mo…
@PacingSpike @PamelaMasonEP @ACCinTouch @EPeeps_Bot @ArunRSridhar @DrRachitaEP @NazemAkoum @KTamirisaMD @rajeshkabramd @MohitTuragam @drrakeshg1 Two RCTs to read up on: EAST AFNET-4: https://t.co/zsRH2cvZvI and EARLY-AF: https://t.co/HicP1vT3LS
RT @DrJasonAndrade: Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to @AHAScienc…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
RT @DrJasonAndrade: We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ab…
We know progression from paroxysmal AF to persistent AF is associated with worse outcomes. And we know Cryoballoon ablation decreases progression vs AAD therapy. Join us at ESC for late-breaking science comparing cryoballoon ablation and RF ablation https://t.co/dO410eFTg3 https://t.co/mtOEGkDebY
#Cryo #PVI vs #AAD in #AF progression https://t.co/kUDKA6W7Vq https://t.co/OZI0vdL2AJ
RT @mduranguerrero: Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/bNCYvxFxdT
RT @DrJasonAndrade: Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to @AHAScienc…
RT @Susumu_Manabe: 心房細動に対するカテーテルvs. 薬物治療。3年での再発率は、カテーテルの方が有意に少ない(56.5% vs, 77.2%)。無作為化比較試験 EARLY-AF試験の結果。 https://t.co/PYdaQaKCQa https://t…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
RT @netta_doc: .@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ab…
.@Dominik_Linz: Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12% ✨Early rhythm control via ablation decreases progression of atrial fibrillation✨ https://t.co/O65uRVhRIO PROGRESSIVE-AF from @DrJasonAndrade: https://t.co/aT7Qoid6XR #WAFib2023 https://t.co/apxeaaoaVQ
Étude qui compare l'ablation par cryoballon à la pharmacothérapie pour le traitement de la fibrillation auriculaire. https://t.co/iQx4hoA1lA #cardiologie https://t.co/yxTkXkWXGz
RT @rythmo_sfc: Un peu de biblio pour bien finir la semaine! 1⃣ Progression de la FA selon la prise en charge anti-arythmique par ablation…
Canadian study suggests it's time to rethink how we treat atrial fibrillation https://t.co/4dRyTR2hgB https://t.co/frOIXNwG76 https://t.co/bODZbybSgP
RT @RevistaMFSamfyc: Progresión de la fibrilación auricular tras crioablación o terapia farmacológica https://t.co/AKQqPLeckI PMID 36342178
RT @rythmo_sfc: Un peu de biblio pour bien finir la semaine! 1⃣ Progression de la FA selon la prise en charge anti-arythmique par ablation…
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/Gi6FN1D6j1
RT @rythmo_sfc: Un peu de biblio pour bien finir la semaine! 1⃣ Progression de la FA selon la prise en charge anti-arythmique par ablation…
Un peu de biblio pour bien finir la semaine! 1⃣ Progression de la FA selon la prise en charge anti-arythmique par ablation ou ttt pharmacologique https://t.co/CMvRPxd0fz
Progresión de la fibrilación auricular tras crioablación o terapia farmacológica https://t.co/AKQqPLeckI PMID 36342178
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
El tratamiento inicial d la fibrilación auricular paroxística con ablación con criobalón se asoció con una menor incidencia d fibrilación auricular persistente o taquiarritmia auricular recurrente durante 3 años d seguimiento que el uso inicial d fármacos. https://t.co/0X4x6QteH0
Initial treatment of paroxysmal AF w catheter cryoballoon ablation was associated with a lower incidence of persistent AF or recurrent atrial tachyarrhythmia over 3yrs of f/up than initial use of anti-arrhythmic drugs https://t.co/dAzjEcjaID
We need to be rethinking how we escalate therapy for patients with afib. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/MuO065k01k
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/aRD53TFFlC
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/YaihayRIXX
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
クライオバルーンアブレーションで発作性AF→持続性AFへの進行を抑制する。クライオvs薬物で持続性AFへの移行率は1.9% vs 7.4%/3年。ICMで評価。 Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/lydSRzsmo5
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
RT @javier20ch: EARLY-AF trial; artículo original por @NEJM
EARLY-AF trial; artículo original por @NEJM
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/5NFIDAUtmx
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jimi_dai: Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/BSw6ljLn8j
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/BSw6ljLn8j
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/bNCYvxFxdT
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
RT @jvillacastin: No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramo…
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/1BpVEc7l1p
Very interesting! Adding data to better care of our patients! Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/jXVyGb46Ch
RT @Sieteenpunto: La crioablación en pacientes con Fibrilación Auricular paroxística disminuyó los episodios de taquiarritmia en los siguie…
No se debe retrasar la ablación de fibrilación auricular. Seleccionando bien a los pacientes y haciéndola pronto mejoramos los resultados. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/NWzSRcr8KD
La crioablación en pacientes con Fibrilación Auricular paroxística disminuyó los episodios de taquiarritmia en los siguientes tres años comparado con tratamiento farmacológico. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/NaJ1jDMw0s
PafにクライオABLするのAAD入れるより、C-A-fibへの移行とか再発とかが少ない。 親父を焼いて欲しかった... Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/vVYwuVKC5S
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/4sLFYtdY07
発作性心房細動に対するクライオ(冷凍)アブレーション クライオアブレーション
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/0PmqSBc0vH
RT @IonicCurrent: 遅ればせながらEARLY-AF試験(NEJM) 治療歴がないpAF303例対象、初回治療cryo-ABLと抗不整脈薬療法を比較し36moでのPeAF発生率は1.9%vs7.4%、36mo入院率5.2%vs16.8%、重篤な有害事象発生率は4.…
遅ればせながらEARLY-AF試験(NEJM) 治療歴がないpAF303例対象、初回治療cryo-ABLと抗不整脈薬療法を比較し36moでのPeAF発生率は1.9%vs7.4%、36mo入院率5.2%vs16.8%、重篤な有害事象発生率は4.5%vs10.1% https://t.co/CsZhAFgyuR
It’s time to rethink how we treat #AFib. A new study from @NEJM shows early intervention with cryoballoon catheter #Ablation is more effective at reducing serious long-term health risks than the current first recommendation of antiarrhythmic drugs. https://t.co/fBiOeKN59p https://t.co/7xf6TtQtCK
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/xwwcmNbR3D
RT @cardio_tu: 2 min cardiology(臨床論文、担当:中野誠) Progression of Atrial Fibrillation after Cryoablation or Drug Therapy J.G. Andrade, et al. DOI…
2 min cardiology(臨床論文、担当:中野誠) Progression of Atrial Fibrillation after Cryoablation or Drug Therapy J.G. Andrade, et al. DOI: 10.1056/NEJMoa2212540 #Cardiology #Ablation
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy https://t.co/UUCxX10bCr
RT @medical_xpress: Canadian study suggests it's time to rethink how we treat #atrialfibrillation @ubcnews @nejm https://t.co/kbxcCUvLwP ht…
Progression of #Atrial #Fibrillation after #Cryoablation or #Drug #Therapy https://t.co/XH0pOMbG7q
RT @JohnHRandall1: Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/ZufJ3FM0s0
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/ZufJ3FM0s0
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/HdM9lZSyql
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy https://t.co/WqMDrtMjJx
RT @medical_xpress: Canadian study suggests it's time to rethink how we treat #atrialfibrillation @ubcnews @nejm https://t.co/kbxcCUvLwP ht…
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/FG7v4UxoY6
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/FG7v4UxoY6
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy https://t.co/xmH0WFhmcH
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/PBEkWpoknE @ignacioDok @FScazzuso
RT @medical_xpress: Canadian study suggests it's time to rethink how we treat #atrialfibrillation @ubcnews @nejm https://t.co/kbxcCUvLwP ht…
Canadian study suggests it's time to rethink how we treat #atrialfibrillation @ubcnews @nejm https://t.co/kbxcCUvLwP https://t.co/qCfhPLjIOV
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy | NEJM https://t.co/JIQ1fU5ppX